preoperatively and postoperatively for each patient: EOS X-ray (ultra-low dose radiation) of the spine in standing position*, MRI of the spine, clinical evaluation, patient self-assessment outcomes including Breast-Q (validated questionnaire in French & English).
RESULTS:
Postoperative improvement in thoracic kyphosis (6 degrees) and lumbar lordosis (3 degrees) are documented quantitatively on patients scanned in the standing position. Preoperative and postoperative MRI of the spine demonstrate no wear and tear. Significant postoperative pain reduction of 81%. Up to 113% improvement in physical tests. Improvement in all Breast-Q categories documented. The measurements will be presented as well as the radiographic evidence.
CONCLUSION:
Reduction mammaplasty is not merely an aesthetic procedure but also a procedure with quantitative spine benefits. This may have an impact on health care system and third-party payer insurance companies and may beckon the need for better guidelines based on those quantitative findings.
*EOS: A Nobel Prize winning imaging technology done in the standing position and which exposes the patient to 1/10 the radiation of a traditional X-Ray of the spine. EOS is the proper name for the imaging technology and it is not an acronym. This technique has demonstrated a significant decrease in incidence of lymphedema, but outpatient therapy has been proposed as an adjuvant to lymphedema prophylaxis. The purpose of this study is to evaluate the combined efficacy of multi-disciplinary outpatient therapy and the LYMPHA microsurgical technique.
QS30 Prophylactic Multidisciplinary Treatment to Reduce the Risk of Lymphedema after Axillary Lymph Node Dissection

METHODS:
All patients with a breast cancer diagnosis over a 6-month period were referred to physical and occupational therapy for pre-operative limb measurements and education regarding arm exercises and self-lymphatic stimulation. All patients undergoing axillary lymph node dissection (ALND) were offered LYMPHA. Patient demographics, operative and pathologic findings, number of LVAs, timing of chemoradiation therapy, and pre-operative and follow-up limb measurements were collected and analyzed.
RESULTS:
Ten patients were included in the analysis. Average age was 52.1 ± 8.9 years; average body mass index was 30.2 ± 6.3 kg/m
2 . An average 17.2 (range 5-26) nodes were excised at the time of ALND with a mean 3.6 (range 1-12) nodes with micro-metastases. Average time since dissection was 124.0 (range 31-220) days. There were 1.6 (range 1-4) LVAs performed per patient. One patient (10%) had early post-operative arm swelling, which resolved following compression therapy. There was an average decrease of 1.1 cm at the proximal upper arm, 0.4 cm at the elbow, 0.2 cm at the distal forearm, and 0.3 cm at the palm. To date, no patient has been demonstrated early signs of lymphedema.
CONCLUSIONS:
A multidisciplinary approach using LYMPHA, pre-operative therapy, and post-operative therapy exhibits potential to reduce the risk of breast cancer related lymphedema in patients undergoing axillary lymph node dissection.
